Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 1013

1.

A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.

Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, Weinehall L.

J Intern Med. 2006 Sep;260(3):263-71. Erratum in: J Intern Med. 2006 Nov;260(5):491.

2.

Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.

Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.

Diabetes Care. 1998 Aug;21(8):1221-5.

PMID:
9702423
3.

HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD; Early Diabetes Intervention Program (EDIP).

Diabetes Care. 2001 Mar;24(3):465-71.

PMID:
11289469
4.

Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.

Hu Y, Liu W, Chen Y, Zhang M, Wang L, Zhou H, Wu P, Teng X, Dong Y, Zhou Jw, Xu H, Zheng J, Li S, Tao T, Hu Y, Jia Y.

Acta Diabetol. 2010 Sep;47(3):231-6. doi: 10.1007/s00592-009-0143-2. Epub 2009 Sep 17.

PMID:
19760291
5.

[Diagnosing type 2 diabetes mellitus: in primary care, fasting plasma glucose and glycosylated haemoglobin do the job].

Jimeno Mollet J, Molist Brunet N, Franch Nadal J, Morató Griera J, Otzet Gramunt I, Pons Barro P.

Aten Primaria. 2004 Sep 30;34(5):222-8. Spanish.

PMID:
15456566
6.
7.

Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.

Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J.

Transplantation. 2009 Aug 15;88(3):429-34. doi: 10.1097/TP.0b013e3181af1f53.

PMID:
19667949
8.

Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.

Ko GT, Chan JC, Tsang LW, Cockram CS.

Diabetes Care. 2000 Dec;23(12):1770-3.

10.

A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.

Narayan KM, Hanson RL, Pettitt DJ, Bennett PH, Knowler WC.

Diabetes Care. 1996 Sep;19(9):972-8.

PMID:
8875091
11.

Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.

Mannucci E, Ognibene A, Sposato I, Brogi M, Gallori G, Bardini G, Cremasco F, Messeri G, Rotella CM.

Acta Diabetol. 2003 Dec;40(4):181-6.

PMID:
14740278
12.

[ADA criteria undervalues the impact of diabetes in a high-risk Spanish population].

Martín Luján F, Costa Pinel B, Donado-Mazarrón Romero A, Basora Gallisà T, Basora Gallisà J, Piñol Moreso JL; Grupo de Investigacion sobre intolerancia a la Glucosa (Reus-Tarragona).

Aten Primaria. 2000 Nov 15;26(8):517-24. Spanish.

PMID:
11149184
13.

The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers.

Inoue K, Matsumoto M, Kobayashi Y.

Diabetes Res Clin Pract. 2007 Sep;77(3):451-8. Epub 2007 Mar 7.

PMID:
17346846
14.
15.
16.

Screening for type 2 diabetes: literature review and economic modelling.

Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.

17.

Fasting plasma glucose in screening for NIDDM in the U.S. and Israel.

Modan M, Harris MI.

Diabetes Care. 1994 May;17(5):436-9.

PMID:
7741837
18.
19.

A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.

Cosson E, Hamo-Tchatchouang E, Banu I, Nguyen MT, Chiheb S, Ba H, Valensi P.

Diabetes Metab. 2010 Sep;36(4):312-8. doi: 10.1016/j.diabet.2010.02.004.

20.

The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors.

Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, Cockram CS.

Ann Clin Biochem. 1998 Jan;35 ( Pt 1):62-7.

PMID:
9463740
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk